A Six Week, Double-Blind Randomized, Efficacy and Safety, Sleep Lab Trial With Esmirtazapine (Org 50081) (P05707)

NCT00506389 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

419

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia

Interventions

DRUG: Esmirtazapine
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]